Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
- Chamber
- Senate
- Introduced
- Apr 21, 2026
- Last action
- Apr 21, 2026 — REFERRED TO HEALTH
- Session
- 2025-2026
- Momentum
- 26 · Low